AG
Algert Global’s Supernus Pharmaceuticals SUPN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-12,920
| Closed | -$437K | – | 1280 |
|
2022
Q3 | $437K | Buy |
12,920
+4,312
| +50% | +$146K | 0.03% | 844 |
|
2022
Q2 | $249K | Buy |
8,608
+1,830
| +27% | +$52.9K | 0.02% | 966 |
|
2022
Q1 | $219K | Buy |
+6,778
| New | +$219K | 0.01% | 1031 |
|
2021
Q4 | – | Sell |
-7,955
| Closed | -$212K | – | 1110 |
|
2021
Q3 | $212K | Buy |
+7,955
| New | +$212K | 0.03% | 889 |
|
2020
Q1 | – | Sell |
-19,090
| Closed | -$453K | – | 513 |
|
2019
Q4 | $453K | Sell |
19,090
-24,033
| -56% | -$570K | 0.14% | 215 |
|
2019
Q3 | $1.19M | Buy |
43,123
+20,913
| +94% | +$575K | 0.44% | 80 |
|
2019
Q2 | $735K | Buy |
22,210
+3,452
| +18% | +$114K | 0.27% | 124 |
|
2019
Q1 | $657K | Sell |
18,758
-6,605
| -26% | -$231K | 0.38% | 99 |
|
2018
Q4 | $843K | Buy |
25,363
+17,302
| +215% | +$575K | 0.24% | 148 |
|
2018
Q3 | $406K | Hold |
8,061
| – | – | 0.09% | 270 |
|
2018
Q2 | $482K | Sell |
8,061
-103,122
| -93% | -$6.17M | 0.1% | 249 |
|
2018
Q1 | $5.09M | Buy |
111,183
+44,320
| +66% | +$2.03M | 0.99% | 4 |
|
2017
Q4 | $2.66M | Buy |
66,863
+4,182
| +7% | +$167K | 0.63% | 49 |
|
2017
Q3 | $2.51M | Buy |
62,681
+10,914
| +21% | +$437K | 0.57% | 63 |
|
2017
Q2 | $2.23M | Sell |
51,767
-6,845
| -12% | -$295K | 0.63% | 46 |
|
2017
Q1 | $1.84M | Buy |
+58,612
| New | +$1.84M | 0.5% | 72 |
|